Cargando…
The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects
INTRODUCTION: Telcagepant (MK-0974) is a novel, orally active and selective CGRP receptor antagonist being investigated for acute treatment of migraine. Early clinical data suggested greater than dose proportional increases in exposure following oral administration. The aim of the present studies wa...
Autores principales: | Han, Tae H, Blanchard, Rebecca L, Palcza, John, Martucci, Ashley, Miller-Stein, Cynthia M, Gutierrez, Maria, Panebianco, Deborah, Rippley, Ronda K, Lines, Christopher, Murphy, M Gail |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015066/ https://www.ncbi.nlm.nih.gov/pubmed/21221171 http://dx.doi.org/10.1111/j.1753-5174.2010.00031.x |
Ejemplares similares
-
Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis☆
por: Yao, Gang, et al.
Publicado: (2013) -
Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment
por: Tfelt-Hansen, Peer
Publicado: (2011) -
Pharmacokinetics of marbofloxacin in pigs after intravenous and intramuscular administration of a single dose of 8 mg/kg: dose proportionality, influence of the age of the animals and urinary elimination
por: Schneider, M, et al.
Publicado: (2014) -
Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects
por: Xie, Ran, et al.
Publicado: (2022) -
Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats
por: Wahajuddin, et al.
Publicado: (2011)